Endo Tools Therapeutics S.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Endo Tools Therapeutics S.A. - overview
Established
2008
Location
-, -, Belgium
Primary Industry
Medical Devices & Equipment
About
Endo Tools Therapeutics S. A. is a medical device company specializing in innovative solutions for gastric conditions, particularly focusing on incisionless surgical techniques to enhance therapeutic interventions for obesity. Founded in 2008 in Belgium, Endo Tools Therapeutics S.
A. develops advanced medical devices for endoscopic procedures. CEO Alexandre Chau leads the company, which has successfully completed 4 deals, with the latest being a Series D funding round in January 2021, raising EUR 8 million from investors including White Fund, Chagral Invest, and Epimède. Endo Tools Therapeutics (ETT) specializes in the development of advanced medical devices aimed at providing innovative therapeutic interventions for gastric conditions, particularly obesity.
The company's core product is the endomina®, which incorporates a triangulation platform and a tissue piercing and approximation instrument known as TAPES. This device allows gastroenterologists to perform endoscopic suturing through a natural orifice—the mouth—thereby facilitating incisionless procedures that mimic laparoscopic interventions. The endomina® and TAPES are CE marked for endoscopic gastroplasty and have received FDA clearance for tissue approximation. ETT's products primarily serve healthcare providers in Europe, where the endomina® procedure has been successfully implemented in over 500 patients, enhancing treatment options for individuals with gastric conditions.
ETT generates revenue through the sale of its specialized medical devices, particularly the endomina® and its associated instruments. The firm typically engages in business-to-business (B2B) transactions, supplying its products directly to hospitals and medical institutions specializing in gastroenterology. Transaction structures often involve bulk purchases or long-term contracts, allowing healthcare providers to access the necessary tools for performing incisionless surgeries. For the year 2023, ETT reported an EBITDA of EUR -4,451,463.
20. Endo Tools Therapeutics S. A. aims to expand its product line and geographic reach, with the intent to introduce new devices designed for enhanced gastric treatments.
The company plans to enter additional European markets by the end of 2023. To support these initiatives, the EUR 8 million raised in Series D funding in January 2021 will be utilized for product development and market penetration strategies.
Current Investors
SFPI-FPIM, Epimede, Chagral Invest
Primary Industry
Medical Devices & Equipment
Sub Industries
Surgical Devices
Website
www.endotools.be
Verticals
HealthTech, Manufacturing
Company Stage
Series D
Total Amount Raised
Subscriber access only
Endo Tools Therapeutics S.A. - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | (197,748) | (208,896) | (136,826) | (301,147) | (301,524) | (434,813) | (661,891) | (818,558) | (1,186,134) | (1,612,085) | (1,896,016) | (1,971,605) | - | - | - |
| Operating Income (USD) | (270,022) | (393,816) | (359,547) | (598,710) | (627,473) | (761,618) | (984,457) | (1,178,691) | (1,551,654) | (2,019,670) | (2,313,586) | (2,440,533) | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| NET Income (USD) | (277,489) | (347,491) | (317,462) | (550,049) | (649,142) | (740,958) | (979,658) | (1,186,989) | (1,567,547) | (2,030,624) | (2,285,104) | (2,452,278) | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Endo Tools Therapeutics S.A. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.